Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C
medRxiv. 2023 May 4:2023.05.03.23289084. doi: 10.1101/2023.05.03.23289084. Preprint.
ABSTRACT
Copyright © 2025 The Board of Regents of the University of Oklahoma. All rights reserved
Disclaimer
|
Copyright
|
Equal Opportunity Employer
Built and Managed by the OCTSI. Base theme by Zymphonies